NO20055417L - Farmasoytisk blanding inneholdene histon-deacetylaseinhibitor - Google Patents

Farmasoytisk blanding inneholdene histon-deacetylaseinhibitor

Info

Publication number
NO20055417L
NO20055417L NO20055417A NO20055417A NO20055417L NO 20055417 L NO20055417 L NO 20055417L NO 20055417 A NO20055417 A NO 20055417A NO 20055417 A NO20055417 A NO 20055417A NO 20055417 L NO20055417 L NO 20055417L
Authority
NO
Norway
Prior art keywords
pharmaceutical composition
composition containing
histone deacetylase
deacetylase inhibitor
containing histone
Prior art date
Application number
NO20055417A
Other languages
English (en)
Other versions
NO20055417D0 (no
Inventor
Osamu Nakanishi
Tatsuo Sugawara
Hideyuki Migita
Yasuhiro Matsuba
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO20055417D0 publication Critical patent/NO20055417D0/no
Publication of NO20055417L publication Critical patent/NO20055417L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Et anticancer-medikament som har en synergistisk effekt ved kombinert anvendelse av et histon-acetylase-derivat så som N-(2-aminofenyl)-4-[N-(pyridinylmetoksykarbonyl)aminometyl]benzamid (MS-275) og en annen anticancer-aktiv substans.
NO20055417A 2003-05-26 2005-11-16 Farmasoytisk blanding inneholdene histon-deacetylaseinhibitor NO20055417L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2003148073 2003-05-26
PCT/JP2004/007562 WO2004103369A1 (en) 2003-05-26 2004-05-26 Pharmaceutical composition containing histone deacetylase inhibitor

Publications (2)

Publication Number Publication Date
NO20055417D0 NO20055417D0 (no) 2005-11-16
NO20055417L true NO20055417L (no) 2005-12-19

Family

ID=33475383

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055417A NO20055417L (no) 2003-05-26 2005-11-16 Farmasoytisk blanding inneholdene histon-deacetylaseinhibitor

Country Status (27)

Country Link
US (1) US20070098816A1 (no)
EP (1) EP1626719A1 (no)
JP (1) JP2006526031A (no)
KR (1) KR100938712B1 (no)
CN (2) CN101322707A (no)
AR (1) AR045318A1 (no)
AU (1) AU2004241873C1 (no)
BR (1) BRPI0410959A (no)
CA (4) CA2527191A1 (no)
CL (1) CL2004001278A1 (no)
CO (1) CO5660262A2 (no)
CR (1) CR8163A (no)
CU (1) CU23490B7 (no)
EC (1) ECSP056253A (no)
IL (1) IL171941A0 (no)
ME (1) MEP32308A (no)
MX (1) MXPA05012345A (no)
NO (1) NO20055417L (no)
NZ (1) NZ543591A (no)
PE (1) PE20050206A1 (no)
RS (1) RS20050884A (no)
RU (1) RU2322971C2 (no)
TW (1) TW200505424A (no)
UA (1) UA81499C2 (no)
UY (1) UY28330A1 (no)
WO (1) WO2004103369A1 (no)
ZA (1) ZA200509515B (no)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO339631B1 (no) * 2004-10-08 2017-01-16 Indena Spa Semisynteseprosess for fremstillingen av 10-deacetyl-N-debenzoyl-paklitaxel.

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6777217B1 (en) 1996-03-26 2004-08-17 President And Fellows Of Harvard College Histone deacetylases, and uses related thereto
US20030129724A1 (en) 2000-03-03 2003-07-10 Grozinger Christina M. Class II human histone deacetylases, and uses related thereto
US7244853B2 (en) 2001-05-09 2007-07-17 President And Fellows Of Harvard College Dioxanes and uses thereof
DK2263694T3 (da) * 2003-09-25 2013-08-26 Astellas Pharma Inc Antitumormiddel omfattende histon-deacetylase-inhibitoren FK228 og topoisomerase-II-inhibitoren doxorubicin
EP1712552A1 (en) * 2005-04-11 2006-10-18 INDENA S.p.A. Semisynthesis process for the preparation of 10-deacetyl-n-debenzoyl-paclitaxel
CA2600845A1 (en) * 2005-03-11 2006-09-21 The Regents Of The University Of Colorado Histone deacetylase inhibitors sensitize cancer cells to epidermal growth factor inhibitors
EP2491926B1 (en) 2005-03-22 2018-05-09 President and Fellows of Harvard College Treatment of protein degradation disorders
EA200800321A1 (ru) 2005-07-14 2008-06-30 Такеда Сан Диего, Инк. Ингибиторы гистондеацетилазы
WO2007095584A2 (en) 2006-02-14 2007-08-23 The President And Fellows Of Harvard College Histone Deacetylase Inhibitors
WO2008091349A1 (en) 2006-02-14 2008-07-31 The President And Fellows Of Harvard College Bifunctional histone deacetylase inhibitors
CA2654540C (en) 2006-05-03 2017-01-17 President And Fellows Of Harvard College Histone deacetylase and tubulin deacetylase inhibitors
GB0625283D0 (en) * 2006-12-19 2007-01-24 Cyclacel Ltd Combination
WO2008082856A1 (en) 2006-12-26 2008-07-10 Pharmacyclics, Inc. Method of using histone deacetylase inhibitors and monitoring biomarkers in combination therapy
WO2009067453A1 (en) * 2007-11-19 2009-05-28 Syndax Pharmaceuticals, Inc. Combinations of hdac inhibitors and proteasome inhibitors
EP2231596A4 (en) * 2007-12-14 2012-06-06 Univ Georgetown INHIBITORS OF HISTONATE ACETYLASE
WO2010011296A2 (en) 2008-07-23 2010-01-28 President And Fellows Of Harvard College Deacetylase inhibitors and uses thereof
JP4921616B2 (ja) * 2008-08-29 2012-04-25 バイエル ファーマ アクチエンゲゼルシャフト Ｎ‐（２‐アミノフェニル）‐４‐［ｎ‐（ピリジン‐３‐イル）‐メトキシカルボニル‐アミノメチル］‐ベンズアミド（ｍｓ‐２７５）結晶多形ｂ
GB2462893B (en) * 2008-08-29 2010-10-13 Bayer Schering Pharma Ag N-(2-aminophenyl)-4-[N-(pyridine-3-yl)-methoxycarbonyl-aminomethyl]-benzamide (MS-275) polymorph B
CA3013000C (en) 2008-12-19 2022-12-13 Vertex Pharmaceuticals Incorporated Pyrazine derivatives useful as inhibitors of atr kinase
WO2010093561A1 (en) * 2009-02-11 2010-08-19 Liangping Yu Particulate composition and the method of making the same
JP2012525371A (ja) * 2009-05-01 2012-10-22 オンコザイム・ファーマ・インコーポレイテッド 癌を治療するためのペンタミジンの組み合わせ
BRPI1010884A2 (pt) * 2009-06-08 2016-03-15 Gilead Sciences Inc composto inibidores hdac de alcanoilamino benzamida anilina
WO2011019393A2 (en) 2009-08-11 2011-02-17 President And Fellows Of Harvard College Class- and isoform-specific hdac inhibitors and uses thereof
MX340670B (es) * 2009-08-25 2016-07-20 Abraxis Bioscience Llc * Terapia combinada con composiciones de nanoparticulas de taxano e inhibidores de hedgehog.
SG185524A1 (en) 2010-05-12 2012-12-28 Vertex Pharma Compounds useful as inhibitors of atr kinase
ES2627820T3 (es) 2011-09-13 2017-07-31 Pharmacyclics, Inc. Formulaciones de inhibidor de histona desacetilasa en combinación con bendamustina y usos de las mismas
CA2850491C (en) * 2011-09-30 2020-10-27 Vertex Pharmaceuticals Incorporated Treating pancreatic cancer and non-small cell lung cancer with atr inhibiors
WO2013049726A2 (en) 2011-09-30 2013-04-04 Vertex Pharmaceuticals Incorporated Processes for making compounds useful as inhibitors of atr kinase
WO2013085902A1 (en) * 2011-12-05 2013-06-13 The University Of Texas M.D. Combination therapy methods for treating an inflammatory breast cancer
MX358818B (es) 2012-04-05 2018-09-05 Vertex Pharma Compuestos utiles como inhibidores de cinasa ataxia telangiectasia mutada y rad3 relacionados (atr) y terapias de combinacion de estos.
WO2014055756A1 (en) 2012-10-04 2014-04-10 Vertex Pharmaceuticals Incorporated Method for measuring atr inhibition mediated increases in dna damage
CA2903473A1 (en) 2013-03-12 2014-10-09 Quanticel Pharmaceuticals, Inc. Histone demethylase inhibitors
US9963452B2 (en) * 2013-03-14 2018-05-08 Augusta Pharmaceuticals Inc. Methods, compounds, and compositions for inhibition of ROS
WO2015127227A1 (en) * 2014-02-21 2015-08-27 Cleveland Biolabs, Inc. Uses of flagellin for improved chemotherapy
KR20170048601A (ko) 2014-09-17 2017-05-08 셀젠 콴티셀 리서치, 인크. 히스톤 탈메틸효소 억제제
CA3000684A1 (en) 2015-09-30 2017-04-06 Vertex Pharmaceuticals Incorporated Method for treating cancer using a combination of dna damaging agents and atr inhibitors
TWI794171B (zh) 2016-05-11 2023-03-01 美商滬亞生物國際有限公司 Ｈｄａｃ抑制劑與ｐｄ-ｌ１抑制劑之組合治療
TWI808055B (zh) 2016-05-11 2023-07-11 美商滬亞生物國際有限公司 Hdac 抑制劑與 pd-1 抑制劑之組合治療
US11596612B1 (en) 2022-03-08 2023-03-07 PTC Innovations, LLC Topical anesthetics

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2697752B1 (fr) * 1992-11-10 1995-04-14 Rhone Poulenc Rorer Sa Compositions antitumorales contenant des dérivés du taxane.
US6794392B1 (en) * 1996-09-30 2004-09-21 Schering Aktiengesellschaft Cell differentiation inducer
JP3354090B2 (ja) * 1996-09-30 2002-12-09 シエーリング アクチエンゲゼルシャフト 分化誘導剤
US6174905B1 (en) * 1996-09-30 2001-01-16 Mitsui Chemicals, Inc. Cell differentiation inducer
US5753637A (en) * 1996-10-09 1998-05-19 Ideal Ideas, Inc. Method of treating acne conditions
ID30046A (id) * 1998-09-25 2001-11-01 Warner Lambert Co Kemoterapi kanker dengan asetildinalina digabung dengan gemsitabina, kapestabina atau kisplatin
CA2369560C (en) * 1999-04-27 2011-02-01 Makoto Nakamuta Agent for prophylaxis and treatment of liver disease
EP1229916A2 (en) * 1999-11-10 2002-08-14 Warner-Lambert Company Combination chemotherapy
US6905669B2 (en) * 2001-04-24 2005-06-14 Supergen, Inc. Compositions and methods for reestablishing gene transcription through inhibition of DNA methylation and histone deacetylase
CZ20022216A3 (cs) * 2001-07-02 2003-05-14 Warner-Lambert Company Kombinační chemoterapie
JP2003137866A (ja) * 2001-11-01 2003-05-14 Sankyo Co Ltd フェニレンジアミン誘導体

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO339631B1 (no) * 2004-10-08 2017-01-16 Indena Spa Semisynteseprosess for fremstillingen av 10-deacetyl-N-debenzoyl-paklitaxel.

Also Published As

Publication number Publication date
CA2634766A1 (en) 2004-12-02
JP2006526031A (ja) 2006-11-16
CA2527191A1 (en) 2004-12-02
KR20060009371A (ko) 2006-01-31
CA2634709A1 (en) 2004-12-02
UA81499C2 (en) 2008-01-10
RU2322971C2 (ru) 2008-04-27
RS20050884A (en) 2008-04-04
EP1626719A1 (en) 2006-02-22
ECSP056253A (es) 2006-10-25
TW200505424A (en) 2005-02-16
AR045318A1 (es) 2005-10-26
CO5660262A2 (es) 2006-07-31
AU2004241873A1 (en) 2004-12-02
CN101322707A (zh) 2008-12-17
CR8163A (es) 2006-07-14
UY28330A1 (es) 2004-12-31
AU2004241873C1 (en) 2009-01-22
CA2634765A1 (en) 2004-12-02
AU2004241873B8 (en) 2008-05-29
PE20050206A1 (es) 2005-03-26
MXPA05012345A (es) 2006-02-08
CN1794991A (zh) 2006-06-28
BRPI0410959A (pt) 2006-07-04
IL171941A0 (en) 2006-04-10
NZ543591A (en) 2009-09-25
RU2005140570A (ru) 2006-06-10
MEP32308A (en) 2010-10-10
NO20055417D0 (no) 2005-11-16
ZA200509515B (en) 2006-07-26
CL2004001278A1 (es) 2005-05-06
US20070098816A1 (en) 2007-05-03
WO2004103369A1 (en) 2004-12-02
AU2004241873B2 (en) 2008-05-08
CU23490B7 (es) 2010-02-23
KR100938712B1 (ko) 2010-01-25

Similar Documents

Publication Publication Date Title
NO20055417L (no) Farmasoytisk blanding inneholdene histon-deacetylaseinhibitor
MXPA06000013A (es) Agente terapeutico para sarcoma de tejido suave.
NO20044744L (no) Karbaminsyreforbindelser omfattende et piperazinledd som HDASinbibitorer
NO20033732L (no) N-substituerte ikke-aryl-heterosykliske NMDA/NR2B-antagonister, og farmasoytiske preparater som omfatter slike forbindelser.
BRPI0414581A (pt) derivados de benzimidazol: preparação e aplicações farmacêuticas
NO20080220L (no) Formuleringer med hoy medikament belastning og doseringsformer
HUP0203330A2 (hu) Benzamidszármazékot tartalmazó javított oldhatóságú és orális felszívódású gyógyszerkészítmények
NO20054681L (no) Farmasoytiske produkter
BR0308081A (pt) Inibidores de histona desacetilase
EA200401200A1 (ru) Карбониламинопроизводные как новые ингибиторы гистондеацетилазы
MXPA06011467A (es) Combinacion de sustancias activas que comprenden un carbinol combinado con al menos un farmaco antiinflamatorio no esteroideo (nsaid).
NO20081038L (no) Farmasoytiske formuleringer/sammensetninger av guanfacin egnet for daglig enkel doseform administrering
HN2003000038A (es) Esteres hidroxamato de acido n-(4-fenil-sustituido)-antranilico
ZA200708749B (en) Hydroxamates as histone deacetylase inhibitors and pharmaceutical formulations containing them
TW200638927A (en) Bambuterol and integrin inhibitor combination
FR2867682B1 (fr) Composition pharmaceutique anhydre associant un agent silicone et un principe actif solubilise.
DE602004020488D1 (de) Mikroemulsionen von retinoiden und diese enthaltende pharmazeutische zusammensetzungen
WO2022169755A8 (en) Sulfonamide substituted n-(1h-indol-7-yl)benzenesulfonamides and uses thereof
PA8633001A1 (es) Composicion farmaceutica antimicobacterial
TW200507838A (en) Active substance combination comprising a 2,5-dihydroxybenzenesulfonic compound and a potassium ion channel modulator
EP4110780A4 (en) COMPOUNDS DERIVED FROM 1,3,4-OXADIAZOLE USED AS HISTONE DEACETYLASE 6 INHIBITORS, AND PHARMACEUTICAL COMPOSITION COMPRISING THEM
EP4110781A4 (en) 1,3,4OXADIAZOLE DERIVATIVE COMPOUNDS AS HISTONEDEACETYLASE-6 INHIBITORS AND PHARMACEUTICAL COMPOSITION THEREOF
AR055107A1 (es) Furoato de n-{2-[((2s)-3-{[1-(4-clorobencil)piperidin-4-il]amino}-2-hidroxi-2-metilpropil)oxi]-4-hidroxifenil} acetamida,composiciones farmaceuticas que los contienen y usos para tratar afecciones o enfermedades donde actuan como moduladores del receptor de quimioquina 1(ccr1)
NO20064337L (no) Farmasoytisk middel inneholdende hyaluronan som en aktiv ingrediens
MXPA02010828A (es) Composicion farmaceutica en capsulas que comprende un antiinflamatorio no esteroideo y un analgesico opiaceo para el manejo del dolor.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application